Impact of rotor ablation in non-paroxysmal AF patients: Findings from the per-protocol population of the OASIS trial at long-term follow-up

Sanghamitra Mohanty; Carola Gianni; Chintan Trivedi; Tamara Metz; Rong Bai; Amin Al-Ahmad; Shane Bailey; John David Burkhardt; G. Joseph Gallinghouse; Rodney Horton; Patrick M. Hranitzky; Javier E. Sanchez; Luigi Di Biase; Andrea Natale

doi:10.1016/j.ahj.2018.05.021

Impact of rotor ablation in non-paroxysmal AF patients: Findings from the per-protocol population of the OASIS trial at long-term follow-up

Sanghamitra Mohanty, Carola Gianni, Chintan Trivedi, Tamara Metz, Rong Bai, Amin Al-Ahmad, Shane Bailey, John David Burkhardt, G. Joseph Gallinghouse, Rodney Horton, Patrick M. Hranitzky, Javier E. Sanchez, Luigi Di Biase, Andrea Natale

Research output: Contribution to journal › Letter › peer-review

15 Scopus citations

Abstract

The objective of this study was to evaluate the long-term efficacy of FIRM ablation with PVAI vs PVAI plus posterior wall isolation (PWI) and non-PV trigger ablation in persistent (PeAF) and long-standing persistent AF (LSPAF) patients. The procedure time was recorded to be 180.6 ± 35.9 and 124.03 ± 45.4 minutes in the FIRM+PVI and PVI + PWI + non-PV trigger ablation group respectively. At 24-month follow-up, 24% (95% CI 8.7%–37.8%) in the FIRM-ablation group and 48% (95% CI 27.6–63.3%) in the non-PV trigger ablation group remained arrhythmia-free off-antiarrhythmic drugs after a single procedure. Clinical Trial Registration: ClinicalTrials.gov (Identifier: NCT02533843).

Original language	English (US)
Pages (from-to)	145-148
Number of pages	4
Journal	American heart journal
Volume	205
DOIs	https://doi.org/10.1016/j.ahj.2018.05.021
State	Published - Nov 2018
Externally published	Yes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.ahj.2018.05.021

Cite this

Mohanty, S., Gianni, C., Trivedi, C., Metz, T., Bai, R., Al-Ahmad, A., Bailey, S., Burkhardt, J. D., Gallinghouse, G. J., Horton, R., Hranitzky, P. M., Sanchez, J. E., Di Biase, L., & Natale, A. (2018). Impact of rotor ablation in non-paroxysmal AF patients: Findings from the per-protocol population of the OASIS trial at long-term follow-up. American heart journal, 205, 145-148. https://doi.org/10.1016/j.ahj.2018.05.021

Mohanty, S, Gianni, C, Trivedi, C, Metz, T, Bai, R, Al-Ahmad, A, Bailey, S, Burkhardt, JD, Gallinghouse, GJ, Horton, R, Hranitzky, PM, Sanchez, JE, Di Biase, L & Natale, A 2018, 'Impact of rotor ablation in non-paroxysmal AF patients: Findings from the per-protocol population of the OASIS trial at long-term follow-up', American heart journal, vol. 205, pp. 145-148. https://doi.org/10.1016/j.ahj.2018.05.021

@article{5bd226276f6143e7814289145b3f9de3,

title = "Impact of rotor ablation in non-paroxysmal AF patients: Findings from the per-protocol population of the OASIS trial at long-term follow-up",

abstract = "The objective of this study was to evaluate the long-term efficacy of FIRM ablation with PVAI vs PVAI plus posterior wall isolation (PWI) and non-PV trigger ablation in persistent (PeAF) and long-standing persistent AF (LSPAF) patients. The procedure time was recorded to be 180.6 ± 35.9 and 124.03 ± 45.4 minutes in the FIRM+PVI and PVI + PWI + non-PV trigger ablation group respectively. At 24-month follow-up, 24% (95% CI 8.7%–37.8%) in the FIRM-ablation group and 48% (95% CI 27.6–63.3%) in the non-PV trigger ablation group remained arrhythmia-free off-antiarrhythmic drugs after a single procedure. Clinical Trial Registration: ClinicalTrials.gov (Identifier: NCT02533843).",

author = "Sanghamitra Mohanty and Carola Gianni and Chintan Trivedi and Tamara Metz and Rong Bai and Amin Al-Ahmad and Shane Bailey and Burkhardt, {John David} and Gallinghouse, {G. Joseph} and Rodney Horton and Hranitzky, {Patrick M.} and Sanchez, {Javier E.} and {Di Biase}, Luigi and Andrea Natale",

year = "2018",

month = nov,

doi = "10.1016/j.ahj.2018.05.021",

language = "English (US)",

volume = "205",

pages = "145--148",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Impact of rotor ablation in non-paroxysmal AF patients

T2 - Findings from the per-protocol population of the OASIS trial at long-term follow-up

AU - Mohanty, Sanghamitra

AU - Gianni, Carola

AU - Trivedi, Chintan

AU - Metz, Tamara

AU - Bai, Rong

AU - Al-Ahmad, Amin

AU - Bailey, Shane

AU - Burkhardt, John David

AU - Gallinghouse, G. Joseph

AU - Horton, Rodney

AU - Hranitzky, Patrick M.

AU - Sanchez, Javier E.

AU - Di Biase, Luigi

AU - Natale, Andrea

PY - 2018/11

Y1 - 2018/11

N2 - The objective of this study was to evaluate the long-term efficacy of FIRM ablation with PVAI vs PVAI plus posterior wall isolation (PWI) and non-PV trigger ablation in persistent (PeAF) and long-standing persistent AF (LSPAF) patients. The procedure time was recorded to be 180.6 ± 35.9 and 124.03 ± 45.4 minutes in the FIRM+PVI and PVI + PWI + non-PV trigger ablation group respectively. At 24-month follow-up, 24% (95% CI 8.7%–37.8%) in the FIRM-ablation group and 48% (95% CI 27.6–63.3%) in the non-PV trigger ablation group remained arrhythmia-free off-antiarrhythmic drugs after a single procedure. Clinical Trial Registration: ClinicalTrials.gov (Identifier: NCT02533843).

AB - The objective of this study was to evaluate the long-term efficacy of FIRM ablation with PVAI vs PVAI plus posterior wall isolation (PWI) and non-PV trigger ablation in persistent (PeAF) and long-standing persistent AF (LSPAF) patients. The procedure time was recorded to be 180.6 ± 35.9 and 124.03 ± 45.4 minutes in the FIRM+PVI and PVI + PWI + non-PV trigger ablation group respectively. At 24-month follow-up, 24% (95% CI 8.7%–37.8%) in the FIRM-ablation group and 48% (95% CI 27.6–63.3%) in the non-PV trigger ablation group remained arrhythmia-free off-antiarrhythmic drugs after a single procedure. Clinical Trial Registration: ClinicalTrials.gov (Identifier: NCT02533843).

UR - http://www.scopus.com/inward/record.url?scp=85053152630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053152630&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2018.05.021

DO - 10.1016/j.ahj.2018.05.021

M3 - Letter

C2 - 30144981

AN - SCOPUS:85053152630

SN - 0002-8703

VL - 205

SP - 145

EP - 148

JO - American Heart Journal

JF - American Heart Journal

ER -

Impact of rotor ablation in non-paroxysmal AF patients: Findings from the per-protocol population of the OASIS trial at long-term follow-up

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this